Bankruptcy News

We've summarized the latest docket activity and news for publicly traded companies currently operating under U.S. Bankruptcy Court protection.

Healthcare Equipment & Services

Unigene Laboratories Chapter 7 Petition Filed

Unigene Laboratories filed for Chapter 7 protection with the U.S. Bankruptcy Court in the District of New Jersey, case number 13-24696. The Company, which engages in biopharmaceutical research, production and drug delivery of small proteins referred to as peptides for therapeutic use, is represented by Matthew E. Tashman of Reed Smith. As a result of the bankruptcy filing, a Chapter 7 trustee will be appointed by the Court and will assume control of the Company. All remaining assets of the Company will be liquidated in accordance with the Bankruptcy Code. According to documents filed with the SEC, concurrent with the Chapter 7 filing, the employment of all remaining employees of the Company, including Ashleigh Palmer, president and C.E.O., and Jack Wyszomierski, C.F.O., treasurer and secretary, was terminated. As a result, the Company no longer has any employees. In addition, Richard Levy, Ashleigh Palmer, Thomas J. Sabatino, Jr., Joel A. Tune and Jack Wyszomierski resigned from the board, and the Company has no current board members.  

Read more Bankruptcy News

Identify & Profit from Distressed Investing

Free Report: Turnaround Investing Mistakes

Turnaround Investing Blog

Turnaround Investing Blog

Is there value in bankrupt PG&E’s stock?

In nearly every case, the shares of a company in bankruptcy become worthless. In very rare cases, however, they can become great investments. W.R. Grace (NYSE:GRA) shares produced a 75-fold return, as an example. With California utility PG&E (NYSE:PCG) now in bankruptcy, the range of possible outcomes for its equity is wide.

Read More.

EV/EBITDA: What Is It & Why Are We Using It More?

In reading recent editions of The Turnaround Letter, you have probably noticed that we are increasingly using EV/EBITDA as a valuation measure, rather than the better-known price/earnings multiple.  We thought it might be useful to describe this measure and why we like it.

Read More.

Turnaround Letter Stock Pick Named Top Performer of 2017

 

stock market advicex

 

What Last Year's Top Stock Pickers Are Buying in 2018

 

This Forbes write-up follows up on the recent Top Stock Tips report--naming The Turnaround Letter's Crocs recommendation the top performer of 2017: With 90% gains, CROX beat out 100 other investment ideas included in the report; and the stock continues to have value investing appeal, according to Putnam.

 

George notes, "We see additional upside for the stock in 2018 as management's efforts continue to bear fruit, though the gains will likely be more muted than we saw in 2017."